Yokoyama Laboratory

Publication in 2009-2010(1)

1	Fukuda, K., Abei, M., Kawashima, R., Ugai, H., Seo, E., Wakayama, M., Murata, T., Endo, S., Hamada, H., Hyodo, I., and Yokoyama, K.: E1A, E1B double restricted adenovirus at low dose augments the efficacy of tumor-specific suicide gene therapy for gallbladder cancer. Cancer Gene therapy 16, 126-136 (2009).
2	Sato, I., Obata, Y., Kasahara, K., Nakayama, Y., Fukumoto, Y., Yamasaki. T., Yokoyama, K., Saito, T., and Yamaguchi, N,; Differential trafficking of c-Src, Lyn, c-Yes, and Fyn is specified by the state of palmitoylation in the SH-4 domain. J. Cell Science 122, 965-975 (2009).
3	Yamasaki, T., Takahashi, A., Pan, J., Yamaguchi, N., and Yokoyama, K.: Phosphorylation of activation transcription factor–2 (ATF-2) at serine　121 by protein kinase C controls c-Jun-mediated activation of transcription. J. Biol. Chemi. 284, 8567-8581 (2009).
4	Weidenfeld-Baranboim, K., Hasin, T., Darlyuk, I., Heinrich, R., Elhanami, O., Pan, J., Yokoyama, K., and Aronheim, A.: The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF-3. Nucleic Acids Res. 37, 2194-2203 (2009).
5	Nakade, K., Pan, J., Yamasaki, T.,, Murata, T., Wasylyk, B., and Yokoyama, K.: Jun dimerization protein-2 deficient mouse embryonic fibroblasts are resistant to replicative senescence. J. Biol. Chem. 284, 10808-10817 (2009).
6	Takahashi, A., Obata, Y., Fuykumoto, Y., Nakayama, Y., Kasahara, K., Kuga, T., Higashiyama, Y., Saito, T., Yokoyama, K., and Yamaguchi, N.: Nuclear localization of Src-family tyrosine kinas is required for growth factor-induced euchromatinization. Exp. Cell Res. 315, 1112-1141 (2009).
7	Murata. T., Pan, J., Hirose, M., Inabe, K., Kujime, Y., Kurihara, C., Kusa, Y., Masuzaki, S., Nakade, K., Nakano, Y., Ohkubo, M., Yamasaki, T., Obata, Y., and Yokoyama, K.: Introduction of recombinant virus bank in RIKEN Gene Engineering Division. Gene Therapy Review 1, 53-57(2009).
8	Hirano, T., and Yokoyama K.: Role of extrachromosomal elements in HL-60 human leukemia cells. Human Genome, Feature, Variation and Genetic Disorders, Chapter 3, Nova Science Publishers, Inc. NY, pp.91-100(2009).
9	Pan, J., Nakade, K., Masuzaki, S., Hasegawa, H., Huang Y-C, Musata, T., Yoshiki, A., Yamaguchi N., Obata, Y. and Yokoyama, K.: Suppression of cell cycle progression by JDP2 involves down-regulation of cyclin A2. Nature Precedings (2009).
10	Nakade, K., Pan, J., Yamasaki, T., Noguchi, M., Masuzaki, S., H. Hasegawa, Kishikawa, S., Murata. T., Zhu, Z-W., Chen, X., Yamaguchi, N., Tsai, E., Lee J. and Yokoyama. K.: Role of histone chaperone JDP2 in replicative senescence. Current Topic of Biochemical Research 11, 75-97 (2009).